-
Mashup Score: 2Your Inhalers and EpiPens Aren’t Very Healthy for the Environment - 8 month(s) ago
For eco-conscious consumers of personal medical devices, recycling options are limited. Some companies are trying to change that.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 92024 Call for Nominations: Expert and Advisory Committees | CADTH - 8 month(s) ago
The Canadian Drug Expert Committee (CDEC) makes reimbursement recommendations for non-oncology pharmaceuticals to the participating federal, provincial, and territorial publicly funded drug plans. It also makes recommendations related to the identification, evaluation, and promotion of optimal drug prescribing and use in Canada. The pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee (pERC) makes reimbursement recommendations for oncology pharmaceuticals to the participating federal,
Source: www.cadth.caCategories: General Medicine News, Hem/OncsTweet-
🚨 Job alert! 🚨 @CADTH_ACMTS is seeking new members to fill multiple positions on its expert and advisory committees (pERC, CDEC, etc). The nomination period goes from March 4 - April 2. #HTA #healtheconomics #hsr #medtwitter #epitwitter Details: https://t.co/bJz0M3Is5B
-
-
Mashup Score: 7Province to pay for continuous glucose monitors, lift age cap on insulin pumps | CBC News - 8 month(s) ago
Responding to years of calls from advocates, Nova Scotia is going to help people with diabetes pay for continuous glucose monitors, and it will remove age restrictions for insulin pumps.
Source: www.cbc.caCategories: General Medicine News, Hem/OncsTweet-
Good news! Nova Scotia announces $7.2 million and removal of age cap (formerly 26) for coverage of continuous glucose monitors and insulin pumps. from @taryngrant @CBCNS https://t.co/I74fwOeFPD
-
-
Mashup Score: 7Efficiency Frontiers to Align Prices and Benefits of Biologic Therapies for Plaque Psoriasis - 9 month(s) ago
This economic evaluation assesses how the efficiency frontier approach could align prices and clinical benefits of biologic medications for plaque psoriasis and estimates price reductions in the US vs 4 peer countries.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Excited to share this new study in @JAMADerm by Alex Egilman and colleagues from @PORTAL_Research. Given restrictions on the use of #QALYs, we used efficiency frontiers assess the relative value of drugs to treat psoriasis. Link: https://t.co/vsUBveWn0I https://t.co/eBvRmK26By
-
-
Mashup Score: 6Climate change and healthcare - 9 month(s) ago
17 January 2024
Source: sites.google.comCategories: General Medicine News, Hem/OncsTweet-
🌎 This week! 🌎 Features a talk by @LichterKatie from the GreenHealth Lab at @UCSF that's well worth a watch. Also, an interview with @Sherilee_H from @UAlbertaSPH and the @IPCC_CH in advance of the next IPCC meeting. Link: https://t.co/7eaetgUhWy #climatechange #healthcare https://t.co/qOWZwHpagf
-
-
Mashup Score: 4Congress’s Misguided Plan to Ban QALYs - 9 month(s) ago
This Viewpoint discusses the flawed assumptions and potential negative impacts of a proposed federal bill that would ban government health care programs from using the quality-adjusted life-year (QALY) and “similar measures” when determining insurance coverage or negotiating prices.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Listening to discussion of #HR485 at @RulesReps and the fundamental misunderstanding about #QALYs and #CEA (generally) is incredibly frustrating. Good time to remind people of this excellent piece in @JAMA_current led by @leah_rand (@PORTAL_Research). https://t.co/l8GJ2agY2o
-
-
Mashup Score: 2
A federal district judge dismissed a lawsuit challenging Medicare’s new drug price negotiation program from the lobbying organization PhRMA.
Source: www.statnews.comCategories: General Medicine News, Hem/OncsTweet-
'A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.' via @statnews https://t.co/JOHHXqOrso
-
-
Mashup Score: 2
A federal district judge dismissed a lawsuit challenging Medicare’s new drug price negotiation program from the lobbying organization PhRMA.
Source: www.statnews.comCategories: General Medicine News, Hem/OncsTweet-
'A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.' via @statnews https://t.co/JOHHXqOrso
-
-
Mashup Score: 20
This economic evaluation estimates US spending on beremagene geperpavec for treating dystrophic epidermolysis bullosa under varying assumptions of cost, the eligible patient population, patient age at diagnosis, and life expectancy.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
🚨 Out today in @JAMADerm! 🚨 Our illustrative analysis of potential spending on a new gene therapy, beremagene geperpavec (B-VEC), for people living with dystrophic epidermolysis bullosa. Co-authors: @akesselheim @AMostaghimi @wbfeldman https://t.co/JEwQma9HGl https://t.co/AeB49kfItq
-
-
Mashup Score: 4Congress’s Misguided Plan to Ban QALYs - 9 month(s) ago
This Viewpoint discusses the flawed assumptions and potential negative impacts of a proposed federal bill that would ban government health care programs from using the quality-adjusted life-year (QALY) and “similar measures” when determining insurance coverage or negotiating prices.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Listening to discussion of #HR485 at @RulesReps and the fundamental misunderstanding about #QALYs and #CEA (generally) is incredibly frustrating. Good time to remind people of this excellent piece in @JAMA_current led by @leah_rand (@PORTAL_Research). https://t.co/l8GJ2agY2o
-
Great article by @TedAlcorn (@nytimes) about plastic use in healthcare & its impact on our environment, specifically from insulin pens & respiratory inhalers. Importantly: recycling programs exist but are energy intensive, likely negating any benefit. 🌎 https://t.co/LaPcgP3GjK